These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 11360738

  • 21. Comparison of two indinavir/ritonavir regimens in the treatment of HIV-infected individuals.
    Acosta EP, Wu H, Hammer SM, Yu S, Kuritzkes DR, Walawander A, Eron JJ, Fichtenbaum CJ, Pettinelli C, Neath D, Ferguson E, Saah AJ, Gerber JG, Adult AIDS Clinical Trials Group 5055 Protocol Team.
    J Acquir Immune Defic Syndr; 2004 Nov 01; 37(3):1358-66. PubMed ID: 15483465
    [Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics and 48 week efficacy of adjusted dose indinavir/ritonavir in rifampicin-treated HIV/tuberculosis-coinfected patients: a pilot study.
    Avihingsanon A, van der Lugt J, Singphore U, Gorowara M, Boyd M, Ananworanich J, Phanuphak P, Burger D, Ruxrungtham K.
    AIDS Res Hum Retroviruses; 2012 Oct 01; 28(10):1170-6. PubMed ID: 22250979
    [Abstract] [Full Text] [Related]

  • 23. Low-dose indinavir in combination with low-dose ritonavir: steady-state pharmacokinetics and long-term clinical outcome follow-up.
    Justesen US, Levring AM, Thomsen A, Lindberg JA, Pedersen C, Tauris P.
    HIV Med; 2003 Jul 01; 4(3):250-4. PubMed ID: 12859324
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetic profile and tolerability of indinavir-ritonavir combinations in healthy volunteers.
    Saah AJ, Winchell GA, Nessly ML, Seniuk MA, Rhodes RR, Deutsch PJ.
    Antimicrob Agents Chemother; 2001 Oct 01; 45(10):2710-5. PubMed ID: 11557459
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of indinavir-ritonavir-based regimens in HIV-1-infected patients with prior protease inhibitor failures.
    Campo RE, Moreno JN, Suarez G, Miller N, Kolber MA, Holder DJ, Shivaprakash M, DeAngelis DM, Wright JL, Schleif WA, Emini EA, Condra JH.
    AIDS; 2003 Sep 05; 17(13):1933-9. PubMed ID: 12960826
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Lopinavir/ritonavir vs. indinavir/ritonavir in antiretroviral naive HIV-infected patients: immunovirological outcome and side effects.
    Bongiovanni M, Bini T, Chiesa E, Cicconi P, Adorni F, Monforte d'Arminio A.
    Antiviral Res; 2004 Apr 05; 62(1):53-6. PubMed ID: 15026202
    [Abstract] [Full Text] [Related]

  • 28. Regimen-dependent variations in adherence to therapy and virological suppression in patients initiating protease inhibitor-based highly active antiretroviral therapy.
    Moore DM, Hogg RS, Yip B, Wood E, Harris M, Montaner JS.
    HIV Med; 2006 Jul 05; 7(5):311-6. PubMed ID: 16945076
    [Abstract] [Full Text] [Related]

  • 29. Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'Ivoire.
    Danel C, Moh R, Peytavin G, Anzian A, Minga A, Gomis OB, Seri B, Nzunettu G, Gabillard D, Salamon R, Bissagnene E, Anglaret X.
    AIDS Res Hum Retroviruses; 2007 Jan 05; 23(1):62-6. PubMed ID: 17263634
    [Abstract] [Full Text] [Related]

  • 30. Efficacy, tolerance, and pharmacokinetics of the combination of stavudine, nevirapine, nelfinavir, and saquinavir as salvage regimen after ritonavir or indinavir failure.
    Casado JL, Dronda F, Hertogs K, Sabido R, Antela A, Martí-Belda P, Dehertogh P, Moreno S, NELSANE Study.
    AIDS Res Hum Retroviruses; 2001 Jan 20; 17(2):93-8. PubMed ID: 11177388
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics of reduced-dose indinavir/ritonavir 400/100 mg twice daily in HIV-1-infected Thai patients.
    Boyd M, Mootsikapun P, Burger D, Chuenyam T, Ubolyam S, Mahanontharit A, Sangkote J, Bunyaprawit P, Horsakulchai M, Lange J, Cooper D, Phanuphak P, Ruxrungtham K.
    Antivir Ther; 2005 Jan 20; 10(2):301-7. PubMed ID: 15865224
    [Abstract] [Full Text] [Related]

  • 32. Overcoming resistance: virologic response to a salvage regimen with the combination of ritonavir plus indinavir.
    Casado JL, Moreno A, Martí-Belda P, Sabido R, Pinheiro S, Bermudez E, Antela A, Dronda F, Perez-Elías MJ, Moreno S.
    HIV Clin Trials; 2003 Jan 20; 4(1):21-8. PubMed ID: 12577193
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetic interaction between indinavir and darunavir with low-dose ritonavir in healthy volunteers.
    Sekar V, Lefebvre E, De Marez T, De Pauw M, De Paepe E, Vangeneugden T, Hoetelmans RM.
    Intervirology; 2010 Jan 20; 53(3):176-82. PubMed ID: 20197684
    [Abstract] [Full Text] [Related]

  • 34. Intracellular accumulation of human immunodeficiency virus protease inhibitors.
    Khoo SH, Hoggard PG, Williams I, Meaden ER, Newton P, Wilkins EG, Smith A, Tjia JF, Lloyd J, Jones K, Beeching N, Carey P, Peters B, Back DJ.
    Antimicrob Agents Chemother; 2002 Oct 20; 46(10):3228-35. PubMed ID: 12234849
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of HIV protease inhibitors on New World Leishmania.
    Demarchi IG, Silveira TG, Ferreira IC, Lonardoni MV.
    Parasitol Int; 2012 Dec 20; 61(4):538-44. PubMed ID: 22579524
    [Abstract] [Full Text] [Related]

  • 37. Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study).
    Lamotte C, Landman R, Peytavin G, Mentre F, Gerbe J, Brun-Vezinet F, Boue F, Spiridon G, Valantin MA, Michelet C, Farinotti R, Yeni P.
    Antivir Ther; 2004 Apr 20; 9(2):247-56. PubMed ID: 15134187
    [Abstract] [Full Text] [Related]

  • 38. Therapeutic drug monitoring of saquinavir in patients during protease inhibitor therapy with saquinavir alone or in combination with ritonavir or nelfinavir.
    Langmann P, Zilly M, Weissbrich B, Schlör C, Väth T, Richter E, Klinker H.
    Eur J Med Res; 2000 Feb 28; 5(2):59-62. PubMed ID: 10720564
    [Abstract] [Full Text] [Related]

  • 39. Plasma population pharmacokinetics and penetration into cerebrospinal fluid of indinavir in combination with zidovudine and lamivudine in HIV-1-infected patients.
    Zhou XJ, Havlir DV, Richman DD, Acosta EP, Hirsch M, Collier AC, Tebas P, Sommadossi JP, AIDS Clinical Trials Study 343 Investigators.
    AIDS; 2000 Dec 22; 14(18):2869-76. PubMed ID: 11153668
    [Abstract] [Full Text] [Related]

  • 40. The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection.
    Katzenstein TL, Kirk O, Pedersen C, Lundgren JD, Nielsen H, Obel N, Nielsen C, Mathiesen LR, Gerstoft J.
    J Infect Dis; 2000 Sep 22; 182(3):744-50. PubMed ID: 10950767
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.